SCP
GH icon

Sender Company & Partners’s Guardant Health GH Stock Holding History

Sender Company & Partners’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-16,170
Closed -$379K – 27
2023
Q1 		$379K Sell
16,170
-36
-0.2% -$1.03K 0.4% 29
2022
Q4 		$441K Buy
+16,206
New +$742K 0.58% 35

Other funds holding GH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Sender Company & Partners's GH Position: Q2 2023 in Review

Sender Company & Partners sold out of Guardant Health (GH) in Q2 2023, closing a stake of 16,170 shares — an estimated $379K sold.

Sender Company & Partners first reported a position in GH in Q4 2022 and held it in 2 quarters. The position peaked at $441K in Q4 2022. 299 funds tracked by Wall St. Rank hold GH as of Q2 2023.

  • Sender Company & Partners reported no remaining Guardant Health position as of Q2 2023 after selling out during the quarter.
  • Sender Company & Partners sold 16,170 Guardant Health shares in Q2 2023, an estimated $379K.
  • Sender Company & Partners first reported a position in Guardant Health in Q4 2022 and held it in 2 quarters.
  • Sender Company & Partners's Guardant Health position peaked at $441K in Q4 2022.
  • 299 funds tracked by Wall St. Rank held Guardant Health as of Q2 2023.

Based on Sender Company & Partners's 13F filing for Q2 2023, filed 14 Aug 2023.